Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 1 Intrathecal Topotecan for Neoplastic Meningitis (PBTC-019)
This study has been completed.
Study NCT00674674   Information provided by Baylor College of Medicine

First Received on December 21, 2007.   Last Updated on May 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplastic Meningitis
Additional conditions recognized in this trial
Meningeal Carcinomatosis
Meningitis
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Neoplasms
Meningeal Neoplasms
Neoplasms
Neoplasms by Site
Nervous System Diseases
Nervous System Neoplasms
Interventions listed in this trial
Topotecan
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Topoisomerase I Inhibitors
Topoisomerase Inhibitors
Sponsors listed in this trial
Baylor College of Medicine
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services